‎Jamjoom Pharma signs binding share subscription deal for biopharma SPV

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) said negotiations related to the non-binding term sheet signed with Pharmaceutical Investment Co. (Lifera), a Public Investment Fund (PIF)-owned company, resulted in Lifera establishing a special purpose vehicle (SPV), referred to as Biologics Co.

The SPV was established to build, own and operate a facility for the manufacturing and commercialization of vaccines, biologics and biosimilars in Saudi Arabia.

Jamjoom Pharmaceuticals Factory Co. (Jamjoom Pharma) said negotiations related to the non-binding term sheet signed with Pharmaceutical Investment Co. (Lifera), a Public Investment Fund (PIF)-owned company, resulted in Lifera establishing a special purpose vehicle (SPV), referred to as Biologics Co.

The SPV was established to build, own and operate a facility for the manufacturing and commercialization of vaccines, biologics and biosimilars in Saudi Arabia.